Cancer News and Research

Latest Cancer News and Research

Closing the 'cancer divide' between developing and developed countries

Noting "there is a huge 'cancer divide' between rich and poor," with more than half of new cancer cases and almost two-thirds of all cancer deaths occurring in developing countries, this year's World Cancer Day theme, "Together It Is Possible," "calls on all individuals, organizations and governments to do their part to reduce premature deaths from cancers by 25 percent by 2025," Felicia Knaul, secretariat for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, and Jonathan Quick, president of Management Sciences for Health, write in a Huffington Post opinion piece.

7 Feb 2012

Cyclin D1 oncogene may promote chromosomal instability

A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of Cancer Biology, have shown in a study published online Feb. 6 in the Journal of Clinical Investigation that the oncogene cyclin D1 may promote a genetic breakdown known as chromosomal instability (CIN). CIN is a known, yet poorly understood culprit in tumor progression.

7 Feb 2012

Inhibiting MET signaling in glioblastoma has major therapeutic value

A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma - the most common and most aggressive malignant brain tumor in humans.

7 Feb 2012

Novel stem-cell technique to enhance bone growth

A research team led by UC Davis Health System scientists has developed a novel technique to enhance bone growth by using a molecule which, when injected into the bloodstream, directs the body's stem cells to travel to the surface of bones.

7 Feb 2012

Komen Foundation works to regain balance in the wake of Planned Parenthood funding flap

News outlets parse different angles of this story -- which broke last week -- including how the Web and social media affected it and how Komen is working to rebuild its donor list.

7 Feb 2012

Whole-genome sequencing helps trace the path of European E. coli outbreak

Using whole-genome sequencing, a team led by researchers from Harvard School of Public Health (HSPH) and the Broad Institute has traced the path of the E. coli outbreak that sickened thousands and killed over 50 people in Germany in summer 2011 and also caused a smaller outbreak in France.

7 Feb 2012

Researchers reveal how molecular imaging can solve breast cancer mysteries

In two new studies featured in the February issue of the Journal of Nuclear Medicine, researchers are revealing how molecular imaging can be used to solve mysteries about difficult cases of breast cancer.

7 Feb 2012

Breathalyzer distinguishes normal and disease-state glucose metabolism

The future of disease diagnosis may lie in a "breathalyzer"-like technology currently under development at the University of Wisconsin-Madison.

7 Feb 2012

EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN

EpiCept Corporation today announced that it has filed for Fast Track designation for AmiKet(amitriptyline 4%, ketamine 2% cream) for the treatment for chemotherapy-induced peripheral neuropathy (CIPN) with the U.S. Food and Drug Administration.

7 Feb 2012

Genomic Health plans to establish wholly owned subsidiary

Genomic Health, Inc. today announced plans to establish a wholly owned subsidiary with the goal of improving the quality of diagnosis, communication and support for millions of patients and their families faced with common and rare genetic conditions.

7 Feb 2012

CRT2012 conference to discuss PCI procedures using CorPath 200 System

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of medicine at Columbia University College of Physicians and Surgeons, New York, N.Y. will present his personal experience using the CorPath 200 System as part of the CorPath PRECISE Trial during a scientific presentation "Cath Lab of the Future: Robotics" at the Cardiovascular Research Technologies' annual meeting, CRT2012.

7 Feb 2012

Researchers discover how SHP-2 genetic defect may result in heart malformation

UNC researchers have discovered how the genetic defect underlying one of the most common congenital heart diseases keeps the critical organ from developing properly. According to the new research, mutations in a gene called SHP-2 distort the shape of cardiac muscle cells so they are unable to form a fully functioning heart.

7 Feb 2012

Preliminary results from Remedy Pharmaceuticals' RP-1127 Phase 2 trial on stroke

Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke Conference in New Orleans on February 2, offer hope to many of these patients.

6 Feb 2012

Researchers describe genetic basis of endometriosis

Researchers at Yale School of Medicine have, for the first time, described the genetic basis of endometriosis, a condition affecting millions of women that is marked by chronic pelvic pain and infertility. The researchers' discovery of a new gene mutation provides hope for new screening methods.

6 Feb 2012

Positive data from Chimerix CMX001 Phase 2 study on CMV disease

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.

6 Feb 2012

Viewpoints: Komen's retreat; Romney's selected support of Medicare cuts; Heritage refuses blame for individual mandate

A group like Komen only has the quality service it provides and goodwill garnered over the years to encourage donations and support. Its trademark pink is not as bold as before. For the moment, it seems drab and faded.

6 Feb 2012

Tanning beds in NSW to be banned by 2014

Australia’s New South Wales (NSW) government announced radical laws that ban commercial tanning beds in the state. NSW will be the only place in the world besides Brazil to institute a total ban on ultraviolet solariums tanning units when the laws come into place from December 31, 2014, and cancer groups hope other states and countries will follow.

6 Feb 2012

Even minimal regular alcohol could harm health say experts

Television adverts are introduced to carry home the message that drinking just a little over the daily recommended alcohol limit can lead to serious health problems. Current medical advice states that men should drink a maximum of four units a day, with women advised to consume no more than three.

6 Feb 2012

Successful six organ transplants in 9 year old

A 9 year old girl from Maine is making recovery days after surgeons transplanted six of her organs in a groundbreaking medical procedure.

6 Feb 2012

Free, online community for oncology nurses

UBM Medica, a recognized leader in medical media and education, and UBM DeusM, the integrated services arm of UBM, today announced the launch of The Oncology Nurse Community (www.theONC.org), a free, online community exclusively for oncology nurses and the cancer care teams that support them.

6 Feb 2012